General MedicationsINJECTIONGeneric

UNIPEN

NAFCILLIN SODIUM

Standard Dose

EQ 10GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Max Dose

Refer to approved labeling

Primary Use

Marketing status: Discontinued

Summary

Approval overview UNIPEN is listed in Drugs@FDA under application 050320 (NDA).

Marketing status: Discontinued Active ingredient NAFCILLIN SODIUM Form and strength INJECTABLE;INJECTION - EQ 10GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor WYETH AYERST Submission history Latest submission status date: 1988-12-19 00:00:00.

Structured Monograph

Clinical summary

Approval overview UNIPEN is listed in Drugs@FDA under application 050320 (NDA). Marketing status: Discontinued Active ingredient NAFCILLIN SODIUM Form and strength INJECTABLE;INJECTION - EQ 10GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor WYETH AYERST Submission history Latest submission status date: 1988-12-19 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Discontinued

Interaction Notes

No interaction notes stored yet.